Managing uncertainty in medicine quality in Ghana

Where regulation is weak, medicine transactions can be characterised by uncertainty over the drug quality and efficacy, with buyers shouldering the greater burden of risk in exchanges that are typically asymmetric. Drawing on in-depth interviews (N = 220) and observations of medicine transactions, plus interviews with regulators (N = 20), the authors explore how people in Ghana negotiate this uncertainty and come to trust a medicine enough to purchase or ingest it.

Read the new article co-authored by Professor Heather Hamill